SWOG'S overall mission is to design, direct, and participate in research that leads to more effective prevention, detection, treatment, and surveillance of cancers in adolescents, young adults, and adults. Our overarching goal is to improve survival, quality of life, and the survivorship experience for those with cancer. The SWOG NCORP Research Base is an integral part of the Group's research effort. The Research Base has the established organizational structure to conduct multi-center prevention, control, and screening/surveillance trials;additionally, we have the successful track record, expertise, and leadership to stimulate and lead cancer care delivery research. We strongly believe, in line with the mission of NCORP, that engaging community oncologists in collaborative research will facilitate the uptake of effective, evidence-based practices.

Public Health Relevance

SWOG will collaboratively design, conduct, and accrue to cancer prevention, control, and screening/surveillance trials, and will study and enhance cancer care delivery, in order to significantly improve the lives of patients.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Clinical Research Cooperative Agreements - Single Project (UG1)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-GRB-I (M1))
Program Officer
Xie, Heng
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oregon Health and Science University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Sucheston-Campbell, Lara E; Clay-Gilmour, Alyssa I; Barlow, William E et al. (2018) Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci. Pharmacogenet Genomics 28:49-55
Carlson, Josh J; Kim, David D; Guzauskas, Gregory F et al. (2018) Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study. Cancer Med 7:4251-4260
Parsons, J Kellogg; Pierce, John P; Mohler, James et al. (2018) Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer. BJU Int 121:534-539
Morgans, Alicia K; Chen, Yu-Hui; Sweeney, Christopher J et al. (2018) Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. J Clin Oncol 36:1088-1095
Klein, Alison P; Wolpin, Brian M; Risch, Harvey A et al. (2018) Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Commun 9:556
Greenlee, Heather; Lew, Danika L; Hershman, Dawn L et al. (2018) Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008). Obesity (Silver Spring) 26:1539-1549
Hershman, Dawn L; Unger, Joseph M; Greenlee, Heather et al. (2018) Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial. JAMA 320:167-176
Chu, Lisa W; Till, Cathee; Yang, Baiyu et al. (2018) Circadian genes and risk of prostate cancer in the prostate cancer prevention trial. Mol Carcinog 57:462-466
Mongiovi, Jennifer M; Zirpoli, Gary R; Cannioto, Rikki et al. (2018) Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221). Breast Cancer Res 20:146
Hershman, Dawn L; Unger, Joseph M; Crew, Katherine D et al. (2018) Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). J Natl Cancer Inst 110:669-676

Showing the most recent 10 out of 143 publications